Table 5 Clinical characteristics of 625 patients.

From: A new glioma grading model based on histopathology and Bone Morphogenetic Protein 2 mRNA expression

Variable

n

Age (year)

IDH1 mutation (yes/no/NA)

1p19q LOH (yes/no/NA)

Mean BMP2

O

174

45.50 ± 1.10

NA

NA

10.34 ± 0.11

OA

127

41.11 ± 1.19

NA

NA

9.96 ± 0.12

A

180

42.02 ± 0.94

NA

NA

9.24 ± 0.12

GBM

144

59.97 ± 1.10

NA

NA

7.79 ± 0.09

Total

625

46.94 ± 0.60

NA

NA

9.36 ± 0.07